newsfilter
← Latest News
GlobeNewswire·

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

● GABAB PAM: Selection of drug candidates under Indivior collaboration expected by end of Q2 2024. Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2024 - Addex Therapeutics